CCO Official Conference Coverage

Updates in HCV Treatment FACULTY: Michael P. Manns, MD David R. Nelson, MD Tram T. Tran, MD 12 Capsule Summaries Expert Analysis Management of HBV, Advanced Liver Disease, and Other Related Complications FACULTY: Robert G. Gish, MD 10 Capsule Summaries

2009 Annual Meeting of the American Association for the Study of Liver Diseases* October 30-November 3, 2009 | Boston, Massachusetts *CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs. Choose from 2 tracks of coverage (mouse over track for more info) Updates in HCV Treatment Management of HBV, Advanced Liver Disease, and Other Related Complications

Robert S. Brown Jr., MD, MPH, has disclosed that he has received consulting fees from Gilead Sciences and Schering-Plough; fees for non-CME/CE services from Gilead Sciences, Roche Pharmaceuticals, and Schering-Plough; and contracted research from Bristol-Myers Squibb, Gilead Sciences, Salix, Schering-Plough, and Vertex.

Peter Ferenci, MD, has disclosed that he has received consulting fees from HGS, Madaus Pharmaceuticals, Novartis, Roche, Tibotec, and Vertex; fees for non-CME/CE services from Roche; and contracted research from Boehringer Ingelheim, Roche, and Tibotec.

Anna S. F. Lok, MD, has disclosed that she has received grants or research support from Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Novartis, Roche, and Schering-Plough and has served as a consultant for Bayer, Bristol-Myers Squibb, Gilead Sciences, and Roche.